Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
批准号:
10534138
负责人:
Linda L. Demer
金额:
$55.29万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2024-12-31
关键词:
AortaAreaArteriesBlood VesselsBone GrowthCalciumCardiacCardiovascular DiseasesCardiovascular systemCathetersCholesterolClinicalClinical ResearchDepositionDietDoseEquilibriumEventExerciseFaceFemaleFluoridesGenetic ModelsGenetic TranscriptionHealth StatusHeterozygoteHormone AntagonistsHormone ReceptorHumanHyperlipidemiaImmunohistochemistryIndividualInjectionsLabelLesionLinkMeasuresMechanicsMineralsModelingMorbidity - disease rateMorphologyMusPTH geneParathyroid Hormone ReceptorParathyroidectomyPathway interactionsPatientsPatternPharmaceutical PreparationsPhysical activityPorosityPositron-Emission TomographyPublic HealthReceptor ActivationRegimenRegulationResearchRiskRoleRuptureSerumSignal TransductionSmooth Muscle MyocytesStrenuous ExerciseStressSurfaceSurgical ModelsTestingTissuesUp-RegulationVascular Smooth MuscleVascular calcificationVascular remodelingbiomechanical testcalcificationcardiovascular disorder riskcardiovascular risk factorcoronary artery calcificationcoronary plaquedensityexercise capacityexperiencegenome wide screenhigh riskimprovedin vivomalemortalitymouse modelnovelnuclear imagingparathyroid hormone-related proteinpharmacologicpredictive modelingreceptor expressionresponsesedentarysensorsexstructural imagingtranscriptometreadmilluptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Vascular calcification, especially coronary artery calcification (CAC), is associated with increased risk of
cardiovascular disease, whereas regular physical activity is associated with decreased risk. Thus, one would
predict that physically active individuals would have less CAC, yet clinical studies show the opposite. Elite
athletes actually have more CAC than their sedentary counterparts even though they have lower cardiac event
rates. The objective of this proposal is to determine the mechanism of this paradox. As clinical studies show
that coronary plaques containing large, contiguous calcium deposits are associated with less cardiovascular
risk than fragmented calcium deposits, one possibility would be that exercise remodels calcium deposits into a
more stable microarchitecture. Theoretical analytical modeling also predicts that decreased surface area of
calcium deposits is expected to reduce plaque rupture risk. Interestingly, a single bout of exercise in humans
and mice causes a transient 1.8-fold elevation of parathyroid hormone (PTH), and intermittent treatment of
PTH in humans and mice causes increased bone growth, which shares signaling mechanisms with vascular
calcification. Our recent findings provide an association between PTH and microarchitecture of vascular
calcium deposits, where intermittent PTH treatment reduces the surface area of aortic calcium deposits in
hyperlipidemic mice with pre-existing vascular calcification. Our preliminary studies provide a more direct
association of exercise with the remodeling of vascular calcium deposits. We found that hyperlipidemic mice
with pre-existing aortic calcification on a 9-week treadmill regimen had increased serum PTH levels, increased
PTH receptor levels in the aortic roots, and decreased mineral surface area by nuclear imaging and
histomorphometry. Thus, we hypothesize that exercise, through activation of the vascular PTH1 receptor,
shifts the microarchitecture of calcium deposits toward a more stabilized form, reducing the rupture risk. We
will test our hypothesis using 3 Specific Aims to determine: 1) whether loss of PTH1 receptor activation
blocks the exercise-induced remodeling of vascular calcium deposits; 2) the relative contributions of circulating
PTH and local (tissue) PTH related peptide (PTHrP) on the exercise-induced changes in microarchitecture;
and 3) effects of confounding factors (sex, exercise dose, diet, and species) on exercise-induced changes in
the SMC transcriptome and vascular calcium deposit microarchitecture. We will use pharmacologic, genetic,
and surgical models, and the endpoints will include progression and microarchitecture of aortic calcium
deposits, including size and surface area based on structural analyses (serial 18F-µPET/µCT,
histomorphometry), transcriptome analysis, and functional biomechanical analyses using a balloon catheter as
a mechanical sensor for rupture vulnerability. The proposed research is significant because it will determine
whether increased vascular calcification with intense exercise is protective or harmful and whether the effects
can be controlled by modulating PTH receptor activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of intermittent activation of parathyroid hormone receptor in exercise-induced vascular calcification
-
批准号:10320968
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2021
-
负责人:Linda L. Demer
-
依托单位:
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease
-
批准号:10365996
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2019
-
负责人:Linda L. Demer
-
依托单位:
Serotonin receptor contribution to inflammation-induced calcific aortic valve disease
-
批准号:9903448
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2019
-
负责人:Linda L. Demer
-
依托单位:
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease
-
批准号:9035205
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2015
-
负责人:Linda L. Demer
-
依托单位:
Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease
-
批准号:8880695
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2015
-
负责人:Linda L. Demer
-
依托单位:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
-
批准号:8535813
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2012
-
负责人:Linda L. Demer
-
依托单位:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
-
批准号:8891481
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:Linda L. Demer
-
依托单位:
Role of Inhibitory SMADs in Calcific Aortic Valve Disease
-
批准号:8352180
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2012
-
负责人:Linda L. Demer
-
依托单位:
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss
-
批准号:8165115
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2011
-
负责人:Linda L. Demer
-
依托单位:
Role of Lymphatic Clearance in Lipid-Induced Calcific Vasculopathy and Bone Loss
-
批准号:8308373
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2011
-
负责人:Linda L. Demer
-
依托单位:
RANKL/OPG-Mediated Control of Vascular Calcification
-
批准号:7413967
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Linda L. Demer
-
依托单位:
RANKL/OPG-Mediated Control of Vascular Calcification
-
批准号:7104587
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2006
-
负责人:Linda L. Demer
-
依托单位:
RANKL/OPG-Mediated Control of Vascular Calcification
-
批准号:7805507
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Linda L. Demer
-
依托单位:
RANKL/OPG-Mediated Control of Vascular Calcification
-
批准号:7227199
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Linda L. Demer
-
依托单位:
RANKL/OPG-Mediated Control of Vascular Calcification
-
批准号:7614521
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Linda L. Demer
-
依托单位:
MOLECULAR AND CELLULAR MECHANISM OF VASCULAR CALCIFICATION
-
批准号:6644324
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2002
-
负责人:Linda L. Demer
-
依托单位:
Lipid Regulation of Vascular and Bone Osteoclastogenesis
-
批准号:6527959
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2001
-
负责人:Linda L. Demer
-
依托单位:
Lipid Regulation of Vascular and Bone Osteoclastogenesis
-
批准号:6439027
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2001
-
负责人:Linda L. Demer
-
依托单位:
Lipid Regulation of Vascular and Bone Osteoclastogenesis
-
批准号:6656298
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2001
-
负责人:Linda L. Demer
-
依托单位:
MOLECULAR AND CELLULAR MECHANISM OF VASCULAR CALCIFICATION
-
批准号:6475033
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2001
-
负责人:Linda L. Demer
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: